Announcements

6 November 2026

Recall of Meravo Film-coated Tablet 100mg

Retail-level recall of one batch of Meravo Film-coated Tablet 100mg (SIN16873P), due to out-of-specification results in stability study

5 November 2026

Malaysian Vape Pod Importer Jailed for 18 Months

5 November 2026

Recall of AGELMIN TABLET 10 mg

Retail-level recall of one batch of AGELMIN TABLET 10 mg due to failed dissolution test results.

4 November 2026

Safeguarding patients from adulterated complementary health products: Responsibilities of TCM practitioners

2 November 2026

Report suspected side effects from medicines to your healthcare professional

1 November 2026

Recall of Tetrabenazine 25mg 112’s Sun-Italy

Retail-level recall of one batch of Tetrabenazine 25mg 112’s Sun-Italy, containing tetrabenazine, due to presence of black spots on the tablets.

29 October 2026

HSA Charges 38-Year-Old Male for Alleged Trafficking of Etomidate Vaporiser Pods

26 October 2026

Mean applicant screening response time

HSA’s target screening turn-around-time from the date of receipt of the application dossier to the date of acceptance or non-acceptance/withdrawal of the application (excluding applicant’s response time) is 50 working days (WD).

21 October 2026

Haze Advisory for Blood Donors

21 October 2026

Recall of DANTRIUM 20 mg Powder for Solution for Injection

Retail-level recall of one batch of DANTRIUM 20 mg Powder for Solution for Injection, containing dantrolene, due to presence of visible foreign particulate matter in the vials.